ADVANCED ENZYME TECHNOLOGIES
|
The Current P/E Ratio of ADVANCED ENZYME TECHNOLOGIES is 28.26.
Share Price | ₹355.5 | Dec 24,2024 |
Market Cap | ₹3,977.5 Cr | |
Earnings-TTM | ₹140.7 Cr | TTM-Consolidated Results |
Price/Earnings | 28.26x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ADVANCED ENZYME TECHNOLOGIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,977.5 Cr] as on Dec 24,2024
(/) Earnings [ ₹140.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.26x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay 28.26 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ADVANCED ENZYME TECHNOLOGIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PE Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 23.76x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 26.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2024 at 29.15x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2020 of 12.36x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 140.74 | 28.26 | 3,977.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.16 | 436,103.0 |
CIPLA LTD | 4,485.22 | 26.58 | 119,196.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.85 | 112,752.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.57 | 97,041.2 |
DIVIS LABORATORIES LTD | 1,836.00 | 83.63 | 153,540.0 |
MANKIND PHARMA LTD | 2,124.86 | 56.51 | 120,073.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.88 | 115,112.0 |
LUPIN LTD | 2,651.94 | 37.30 | 98,925.3 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.37 | 73,314.6 |
ABBOTT INDIA LTD | 1,284.66 | 47.08 | 60,480.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.37x |
Max industry PE | 83.63x |
Median industry PE | 37.30x |
Average industry PE | 40.56x |
You may also like the below Video Courses